Health Boards
Wed-25-11-2015, 21:21 PM
Is this purely on cost they have rejected it ?
That doesn't sound expensive to me I'm sure other drugs cost more, and Otezla has had some success. I don't understand why it's not being approved
Quote:The price of apremilast is £265.18 for a 14-day treatment initiation pack (4×10 mg tablet; 4×20 mg tablet; 19×30 mg tablet) and £550.00 for a 28-day-treatment standard pack (56×30 mg) (excluding VAT; ‘Monthly Index of Medical Specialities’ [MIMS] online accessed March 2015). The cost of 12 months of treatment with apremilast is estimated at £7140.18 (company submission). Costs may vary in different settings because of negotiated procurement discounts.
That doesn't sound expensive to me I'm sure other drugs cost more, and Otezla has had some success. I don't understand why it's not being approved
